- Home
- SBFM vs MSDL Comparison
SBFM vs MSDL Comparison
Compare SBFM & MSDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- MSDL
- Stock Information
- Founded
- SBFM 2006
- MSDL 2019
- Country
- SBFM United States
- MSDL United States
- Employees
- SBFM N/A
- MSDL N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- MSDL
- Sector
- SBFM Health Care
- MSDL
- Exchange
- SBFM Nasdaq
- MSDL NYSE
- Market Cap
- SBFM 6.6M
- MSDL 1.7B
- IPO Year
- SBFM N/A
- MSDL N/A
- Fundamental
- Price
- SBFM $1.54
- MSDL $19.25
- Analyst Decision
- SBFM Strong Buy
- MSDL Hold
- Analyst Count
- SBFM 1
- MSDL 5
- Target Price
- SBFM $15.00
- MSDL $20.00
- AVG Volume (30 Days)
- SBFM 186.2K
- MSDL 423.2K
- Earning Date
- SBFM 08-15-2025
- MSDL 01-01-0001
- Dividend Yield
- SBFM N/A
- MSDL 11.46%
- EPS Growth
- SBFM N/A
- MSDL N/A
- EPS
- SBFM N/A
- MSDL N/A
- Revenue
- SBFM $36,234,578.00
- MSDL N/A
- Revenue This Year
- SBFM $192.48
- MSDL $1,597.39
- Revenue Next Year
- SBFM N/A
- MSDL $15.10
- P/E Ratio
- SBFM N/A
- MSDL N/A
- Revenue Growth
- SBFM 35.51
- MSDL N/A
- 52 Week Low
- SBFM $1.17
- MSDL $17.59
- 52 Week High
- SBFM $7.10
- MSDL $23.63
- Technical
- Relative Strength Index (RSI)
- SBFM 51.91
- MSDL 50.38
- Support Level
- SBFM $1.43
- MSDL $18.84
- Resistance Level
- SBFM $1.61
- MSDL $19.19
- Average True Range (ATR)
- SBFM 0.11
- MSDL 0.28
- MACD
- SBFM 0.01
- MSDL 0.02
- Stochastic Oscillator
- SBFM 41.67
- MSDL 75.95
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About MSDL MORGAN STANLEY DIRECT LENDING FUND
Morgan Stanley Direct Lending Fund is a fund whose investment objective is to achieve attractive risk-adjusted returns via current income and to a lesser extent, capital appreciation by investing predominantly in directly originated senior secured term loans issued by U.S. middle-market companies backed by private equity sponsors. It invests predominantly in directly originated senior secured term loans including first lien senior secured term loans including unitranche loans and second lien senior secured term loans, with the balance of the investments expected to be in higher-yielding assets such as mezzanine debt, unsecured debt, equity investments and other opportunistic asset purchases.